AI assistant
Sending…
InfuSystem Holdings, Inc — Director's Dealing 2020
May 23, 2020
33639_dirs_2020-05-22_bdf14686-e484-4ed8-aa63-61d8dfd524e5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: InfuSystem Holdings, Inc (INFU)
CIK: 0001337013
Period of Report: 2020-05-20
Reporting Person: GENDRON PAUL ANDREW (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-05-20 | Stock Option (right to buy) | $11.07 | A | 25000 | Acquired | 2030-05-20 | Common Stock (25000) | Direct |
Footnotes
F1: The stock option was issued with an exercise price equal to the Fair Value as defined by the 2014 Equity Plan, which is computed as the average closing price of the Company's common stock reported on the NYSE American LLC for the five (5) most recent trading days prior to the date of grant.
F2: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning June 20, 2020.
More from InfuSystem Holdings, Inc
Transaction in Own Shares
2026
May 18
Regulatory Filings
2026
May 18
Board/Management Information
2026
May 14
Interim / Quarterly Report
2026
May 8
Report Publication Announcement
2026
May 7
Regulatory Filings
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 10
Regulatory Filings
2026
Mar 19
Director's Dealing
2026
Mar 3
Investor Presentation
2026
Feb 27